样本人工交叉校验 · 10 条

这是蒸馏管线生成数据的人工抽检底线(计划 Phase 3.6)。请独立判断, 不要先看每条最后折叠的“系统自动判定”(防止被带偏,评完该条再展开对比)。
三个维度:① 科学性=问题是否有生物医学意义; ② 依据性=问题相对“源摘要”是否站得住(具体术语在摘要外但点 PMID 全文能查到,选“术语需查全文”,不算超源); ③ Preference=仅对进入 DPO 偏好对的条目,判“胜出问题确实更优”是否成立。
评完点底部导出评审 JSON,把文件回传即可。进度自动本地保存,可分次完成。

#1   PMID 2017227 (点 PMID 看全文核实)

Preoperative transcatheter closure of congenital muscular ventricular septal defects.
源摘要(QG 实际输入)
BACKGROUND: Surgical repair of muscular ventricular septal defects, particularly those associated with complex heart lesions carries a higher risk of reoperation and death than the repair of membranous defects. Closing a muscular defect through an incision in the systemic ventricle may cause late ventricular dysfunction. In a collaborative approach to this problem, we undertook preoperative transcatheter closure of muscular ventricular septal defects remote from the atrioventricular and semilunar valves, followed by the surgical repair of associated conditions. METHODS: In 12 patients selected jointly by a cardiologist and a cardiac surgeon, we attempted preoperative transcatheter umbrella closure of 21 defects. Half the patients had associated complex heart lesions; the others had had pulmonary-artery banding to reduce the amount of left-to-right shunting. Half had severe ventricular septal deficiency. RESULTS: All 21 defects were successfully closed without major complications. Subsequent cardiac surgery for associated conditions in 11 of the 12 patients resulted in a mean pulmonary-to-systemic flow ratio of 1.1, indicating minimal residual left-to-right shunting; 1 patient awaited surgical repair. No deaths, reoperations, or late complications have occurred after a follow-up of 7 to 20 months. CONCLUSIONS: A collaborative approach using transcatheter closure followed by the surgical repair of associated cardiac lesions may decrease rates of operative mortality, reoperation, and left ventricular dysfunction in patients with muscular ventricular septal defects.
Q_low:Does preoperative transcatheter closure of muscular ventricular septal defects followed by surgical repair of associated cardiac lesions reduce the risk of late ventricular dysfunction compared to surgical repair alone?
Q_high:How does preoperative transcatheter closure of muscular ventricular septal defects affect the risk of late ventricular dysfunction compared with surgical repair that involves an incision in the systemic ventricle?
生成的答案(基于检索上下文,非源文档)
Based on the provided contexts, preoperative transcatheter closure of congenital muscular ventricular septal defects is associated with a **decreased risk of late left ventricular dysfunction** compared to surgical repair that involves an incision in the systemic ventricle. Context [1] explicitly states that closing a muscular defect through an incision in the systemic ventricle "may cause late ventricular dysfunction." Consequently, the study concludes that a collaborative approach using preoperative transcatheter closure followed by surgical repair of associated lesions "may decrease rates of... left ventricular dysfunction." *Note: Contexts [2], [3], and [4] discuss transcatheter closure in the settings of ischemic/post-traumatic defects or membranous defects and do not provide specific comparative data regarding late ventricular dysfunction for congenital muscular defects versus surgical incision.*
1. 科学性:两个问题是否是有意义的生物医学问题?
2. 依据性:问题相对“源摘要”是否站得住(全文存疑可点 PMID 核)?
3. Preference(该条进入了 DPO 偏好对)
胜出问题:How does preoperative transcatheter closure of muscular ventricular septal defects affect the risk of late ventricular dysfunction compared with surgical repair that involves an incision in the systemic ventricle?
相对另一候选问题,胜出问题+其答案 确实更值得作为"更优"样本 吗?
备注
⚠️ 评完本条后再展开:系统自动判定(对比用,勿先看)
rubric=b / reason=llm_judge / verification=grounded

#2   PMID 26531737 (点 PMID 看全文核实)

Low-intensity pulsed ultrasound treatment as an alternative to vascular bone graft surgery for a 5-year-long ulnar non-union in a patient with haemochromatosis.
源摘要(QG 实际输入)
We present the case of a 75-year-old woman with haemochromatosis who developed a 5-year-long right ulnar non-union after a shortening osteotomy to correct a malunited Colles' fracture. Standard surgical treatment for ulnar non-unions was attempted on 19 March 2008 and again on 20 April 2009, but the non-union persisted on 8 May 2012, as confirmed by CT scan. Vascular bone grafting and refixation was then considered, but the patient declined this extensive operation, instead choosing to try non-invasive low-intensity pulsed ultrasound treatment with an Exogen device. Just 4 months later, complete union as confirmed by CT scan was achieved. This is the first case demonstrating the efficacy of ultrasound treatment for long-standing non-unions resistant to surgery in patients with haemochromatosis, a disorder where iron deposition can provide suboptimal circumstances for bone healing. Our finding suggests that low-intensity pulsed ultrasound devices could be used as a first-line treatment for stable non-unions instead of revision surgery.
Q_low:Does low-intensity pulsed ultrasound treatment promote bone union in patients with haemochromatosis?
Q_high:Why does low-intensity pulsed ultrasound treatment promote bone union in patients with haemochromatosis despite iron deposition creating suboptimal circumstances for healing?
生成的答案(基于检索上下文,非源文档)
Yes, based on the provided context, low-intensity pulsed ultrasound treatment promoted bone union in a patient with haemochromatosis. Specifically, a 75-year-old woman with haemochromatosis and a 5-year-long ulnar non-union achieved complete union just 4 months after starting the treatment, following the failure of standard surgical interventions. This case is noted as the first demonstration of the efficacy of this treatment for long-standing non-unions in patients with haemochromatosis.
1. 科学性:两个问题是否是有意义的生物医学问题?
2. 依据性:问题相对“源摘要”是否站得住(全文存疑可点 PMID 核)?
3. Preference(该条进入了 DPO 偏好对)
胜出问题:Does low-intensity pulsed ultrasound treatment promote bone union in patients with haemochromatosis?
相对另一候选问题,胜出问题+其答案 确实更值得作为"更优"样本 吗?
备注
⚠️ 评完本条后再展开:系统自动判定(对比用,勿先看)
rubric=a / reason=hard_gate / verification=grounded

#3   PMID 20015568 (点 PMID 看全文核实)

Disinvestment for re-allocation: a process to identify priorities in healthcare.
源摘要(QG 实际输入)
Resource scarcity and increasing service demand lead health systems to cope with choices within constrained budgets. The aim of the paper is to describe the study carried out in the Tuscan Health System in Italy on how to set priorities in the disinvestment process for re-allocation. The analysis was based on 2007 data benchmarking of the Tuscan Health System with an impact on the level of resources used. For each indicator, the first step was to estimate the gap between the performance of each Health Authority (HA) and the best performance or the regional average. The second step was to measure this gap in terms of financial value. The results of the analysis demonstrated that, at the regional level, 2-7% of the healthcare budget can be re-allocated if all the institutions achieve the regional average or the best practice. The implications of this study can be useful for policy makers and the HA top management. In the context of resource scarcity, it allows managers to identify the areas where the institutions can achieve a higher level of efficiency without negative effects on quality of care and instead re-allocate resources toward services with more value for patients.
Q_low:Can reallocating healthcare resources from low-efficiency services to high-value services improve patient outcomes without negatively affecting the quality of care?
Q_high:How does benchmarking performance against regional averages or best practices enable the identification of opportunities to re-allocate healthcare resources without negative effects on the quality of care?
生成的答案(基于检索上下文,非源文档)
Based on the provided contexts, benchmarking enables the identification of opportunities to re-allocate resources by allowing healthcare organizations to compare their practices, processes, and outcomes with others to discover "best practices" (Context 3). This comparison helps address the high variability in the quality of care and outcomes (Context 4) and serves as a performance improvement method to enhance efficiency and cost-effectiveness (Context 2). However, the provided contexts **do not explicitly state** how benchmarking specifically enables the identification of resource re-allocation opportunities *without negative effects on the quality of care*. While Context 2 notes the potential to improve quality and Context 4 mentions using risk-adjusted outcomes to address variability, neither text details the specific mechanism by which re-allocating resources based on these benchmarks avoids compromising care quality.
1. 科学性:两个问题是否是有意义的生物医学问题?
2. 依据性:问题相对“源摘要”是否站得住(全文存疑可点 PMID 核)?
3. Preference(该条进入了 DPO 偏好对)
胜出问题:How does benchmarking performance against regional averages or best practices enable the identification of opportunities to re-allocate healthcare resources without negative effects on the quality of care?
相对另一候选问题,胜出问题+其答案 确实更值得作为"更优"样本 吗?
备注
⚠️ 评完本条后再展开:系统自动判定(对比用,勿先看)
rubric=b / reason=llm_judge / verification=partial

#4   PMID 20132657 (点 PMID 看全文核实)

In vitro cell cycle dynamics of primitive hematopoietic cells from human umbilical cord blood.
源摘要(QG 实际输入)
The goal of the present study was to investigate the specific way in which recombinant stimulatory cytokines modulate the cell cycle dynamics of primitive hematopoietic cells in vitro. A human cord blood-derived cell population, enriched for CD34(+) Lin(-) cells, was obtained by negative selection and cultured in liquid cultures, in the absence or presence of recombinant stimulatory cytokines. The proportion of cells in each phase of the cell cycle, as well as the expression of cyclin D3, cyclin-dependent kinase-4 (cdk4), p16, p21 and p27, was determined at different time points. At the onset of culture, the vast majority of the cells were in the G(0)/G(1) phase of the cell cycle. In the absence of cytokines, most cells remained in such a phase and no cell cycle activity was detected throughout the culture period, which correlated with the absence of population doublings. In the presence of cytokines, approximately four cell cycles, with a proportionate population doubling, were observed within the first 4 days of culture. In cultures incorporating cytokines, expression levels of cyclin D3 and cdk4 were higher than in their absence; in contrast, the levels of the cell cycle inhibitors p16 and p21 were higher in cultures without cytokines. Levels of p27 were also higher in the presence of cytokines. Our results indicate that the proliferation of primitive hematopoietic cells in liquid culture is promoted by recombinant cytokines via the induction of specific positive regulators of the cell cycle and down-regulation of particular cell cycle inhibitors.
Q_low:Do recombinant stimulatory cytokines promote the proliferation of primitive hematopoietic cells by inducing positive regulators of the cell cycle and down-regulating specific cell cycle inhibitors?
Q_high:Why does the presence of recombinant cytokines promote cell cycle progression in primitive hematopoietic cells compared to their absence?
生成的答案(基于检索上下文,非源文档)
Based on the provided contexts, the presence of recombinant cytokines promotes cell cycle progression in primitive hematopoietic cells through the following mechanisms: * **Regulation of Cell Cycle Proteins:** Cytokines induce the expression of positive cell cycle regulators, specifically **cyclin D3** and **cyclin-dependent kinase-4 (cdk4)**, while simultaneously down-regulating cell cycle inhibitors such as **p16** and **p21**. * **Synergistic Enhancement:** Cytokines can act synergistically to enhance cell cycle entry; for example, **GM-CSF** enhances stem cell factor (SCF)-induced cell cycle entry in primitive progenitors, even though it has minimal effects when added alone. * **Modulation of Proliferation Kinetics:** While the initial exit from quiescence (G0) may be stochastic, cytokines modulate the kinetics of proliferation beyond the initial division, facilitating synchronized cell cycles and maintaining the long-term culture-initiating cell (LTC-IC) function. * **Reduction of Apoptosis:** Specific cytokine combinations (e.g., flt-3 ligand) can significantly decrease apoptosis, thereby supporting the survival of cells entering the active cell cycle. In the absence of these cytokines, cells generally remain in the G0/G1 phase with no detectable cell cycle activity or population doubling.
1. 科学性:两个问题是否是有意义的生物医学问题?
2. 依据性:问题相对“源摘要”是否站得住(全文存疑可点 PMID 核)?
3. Preference(该条进入了 DPO 偏好对)
胜出问题:Why does the presence of recombinant cytokines promote cell cycle progression in primitive hematopoietic cells compared to their absence?
相对另一候选问题,胜出问题+其答案 确实更值得作为"更优"样本 吗?
备注
⚠️ 评完本条后再展开:系统自动判定(对比用,勿先看)
rubric=b / reason=llm_judge / verification=hallucinated

#5   PMID 23790130 (点 PMID 看全文核实)

Subthreshold depression and subjective cognitive complaints in Parkinson's disease.
源摘要(QG 实际输入)
BACKGROUND AND PURPOSE: Subthreshold depression (SubD) is characterized by clinically relevant depressive symptoms not meeting criteria for major depression. The possible association of SubD with subjective cognitive complaints and/or objective cognitive impairments was investigated in a sample of consecutive, non-demented Parkinson's disease (PD) outpatients. METHODS: Amongst 115 patients, SubD was identified in 30 patients, major depression in 33; 36 patients were classified as non-depressed. Enrolled patients were administered tests and questionnaires validated in PD for assessing objective and subjective cognitive dysfunctions. RESULTS: On objective cognitive measures SubD patients did not differ from non-depressed patients, whereas depressed patients achieved significantly lower scores than the other two groups. SubD and depressed patients reported more cognitive complaints than non-depressed patients. CONCLUSIONS: SubD is a non-motor aspect of PD that is not related to objective cognitive deficits but is associated with subjective cognitive complaints, thus impacting on patients' well-being.
Q_low:Is subthreshold depression associated with subjective cognitive complaints in patients with Parkinson's disease?
Q_high:How does the presence of subthreshold depression affect subjective cognitive complaints in non-demented Parkinson's disease patients compared to non-depressed patients?
生成的答案(基于检索上下文,非源文档)
Yes, subthreshold depression is associated with subjective cognitive complaints in patients with Parkinson's disease. According to the provided contexts, specifically the study with pmid=23790130, patients with subthreshold depression reported more cognitive complaints than non-depressed patients, despite not showing differences in objective cognitive measures. Additionally, the study with pmid=24909761 notes that significant depressive symptoms increase subjective memory complaints across all cognitive status groups in PD patients.
1. 科学性:两个问题是否是有意义的生物医学问题?
2. 依据性:问题相对“源摘要”是否站得住(全文存疑可点 PMID 核)?
备注
⚠️ 评完本条后再展开:系统自动判定(对比用,勿先看)
rubric=tie / reason=tie / verification=grounded

#6   PMID 9576245 (点 PMID 看全文核实)

Proton magnetic resonance spectroscopy for detection of axonal injury in the splenium of the corpus callosum of brain-injured patients.
源摘要(QG 实际输入)
OBJECT: This study was conducted to determine whether proton magnetic resonance spectroscopy (MRS) is a sensitive method for detecting diffuse axonal injury, which is a primary sequela of traumatic brain injury (TBI). Diffuse axonal injury is characterized by selective damage to white matter tracts that is caused in part by the severe inertial strain created by rotational acceleration and deceleration, which is often associated with motor vehicle accidents. This axonal injury is typically difficult to detect by using conventional imaging techniques because it is microscopic in nature. The splenium was selected because it is a site vulnerable to shearing forces that produce diffuse axonal injury. METHODS: The authors used proton MRS to evaluate the splenium, the posterior commissure of the corpus callosum, in normal control volunteers and in patients with TBI. Proton MRS provided an index of neuronal and axonal viability by measuring levels of N-acetyl aspartate (NAA). CONCLUSIONS: A majority of mildly brain injured patients, as well as those more severely injured, showed diminished NAA/creatine (Cr) levels in the splenium compared with normal control volunteers. The patients displaying lowered NAA/Cr in the splenium were also likely to exhibit lowered NAA/Cr in lobar white matter. Also, the levels of NAA/Cr in the splenium of normal volunteers were higher compared with those found in lobar white matter. Decreases in NAA/Cr levels in the splenium may be a marker for diffuse injury. A proton MRS examination may be particularly useful in evaluating mildly injured patients with unexplained neurological and cognitive deficits. It is concluded that MRS is a sensitive tool in detecting axonal injury.
Q_low:Is N-acetyl aspartate to creatine ratio in the splenium of the corpus callosum lower in patients with traumatic brain injury compared to normal controls?
Q_high:Why does proton magnetic resonance spectroscopy detect axonal injury in the splenium of brain-injured patients when conventional imaging techniques fail?
生成的答案(基于检索上下文,非源文档)
Proton magnetic resonance spectroscopy (MRS) detects axonal injury in the splenium when conventional imaging fails because diffuse axonal injury is **microscopic in nature**, whereas conventional imaging techniques cannot detect such microscopic damage. MRS overcomes this limitation by measuring neurochemical markers, specifically **N-acetyl aspartate (NAA)** levels, which serve as an index of neuronal and axonal viability; a decrease in NAA indicates axonal injury even in the absence of macroscopic abnormalities visible on standard imaging.
1. 科学性:两个问题是否是有意义的生物医学问题?
2. 依据性:问题相对“源摘要”是否站得住(全文存疑可点 PMID 核)?
3. Preference(该条进入了 DPO 偏好对)
胜出问题:Why does proton magnetic resonance spectroscopy detect axonal injury in the splenium of brain-injured patients when conventional imaging techniques fail?
相对另一候选问题,胜出问题+其答案 确实更值得作为"更优"样本 吗?
备注
⚠️ 评完本条后再展开:系统自动判定(对比用,勿先看)
rubric=b / reason=llm_judge / verification=grounded

#7   PMID 29039578 (点 PMID 看全文核实)

The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma.
源摘要(QG 实际输入)
Accumulating evidence indicates that mitotic checkpoint serine/threonine kinase B (BUB1B) plays a critical role in multiple types of cancer. However, the biological function and molecular regulatory mechanism of BUB1B in glioblastoma (GBM) remain unclear. In the present study, we identified that BUB1B expression was enriched in GBM tumors and was functionally required for tumor proliferation both in vitro and in vivo. Clinically, BUB1B expression was associated with poor prognosis in GBM patients and BUB1B‑dependent radioresistance in GBM was decreased by targeting BUB1B via shRNAs. Mechanistically, forkhead box protein M1 (FOXM1) transcriptionally regulated BUB1B expression by binding to and then activating the BUB1B promoter. Therapeutically, we found that FOXM1 inhibitor attenuated tumorigenesis and radioresistance of GBM both in vitro and in vivo. Altogether, BUB1B promotes tumor proliferation and induces radioresistance in GBM, indicating that BUB1B could be a potential therapeutic target for GBM.
Q_low:Does BUB1B expression promote tumor proliferation and induce radioresistance in glioblastoma?
Q_high:How does the transcriptional regulation of BUB1B by FOXM1 affect the radioresistance of glioblastoma?
生成的答案(基于检索上下文,非源文档)
Based on the provided contexts, the transcriptional regulation of **BUB1B** by **FOXM1** affects the radioresistance of glioblastoma in the following way: * **Mechanism:** FOXM1 transcriptionally regulates BUB1B expression by binding to and activating the **BUB1B promoter**. * **Effect on Radioresistance:** This regulation promotes **radioresistance** in glioblastoma. Specifically, BUB1B expression is functionally required for tumor proliferation and induces radioresistance; consequently, targeting BUB1B (e.g., via shRNAs) decreases BUB1B-dependent radioresistance. * **Therapeutic Implication:** Inhibiting FOXM1 attenuates both tumorigenesis and radioresistance, suggesting that the FOXM1/BUB1B signaling pathway is essential for these processes in glioblastoma. *Note: While Context [2], [3], and [4] describe other FOXM1-mediated mechanisms for radioresistance (involving STAT3, Sox2, and Rad51, respectively), only Context [1] explicitly details the FOXM1-BUB1B axis.*
1. 科学性:两个问题是否是有意义的生物医学问题?
2. 依据性:问题相对“源摘要”是否站得住(全文存疑可点 PMID 核)?
3. Preference(该条进入了 DPO 偏好对)
胜出问题:How does the transcriptional regulation of BUB1B by FOXM1 affect the radioresistance of glioblastoma?
相对另一候选问题,胜出问题+其答案 确实更值得作为"更优"样本 吗?
备注
⚠️ 评完本条后再展开:系统自动判定(对比用,勿先看)
rubric=b / reason=hard_gate / verification=grounded

#8   PMID 11528208 (点 PMID 看全文核实)

Effects of sex hormones on Na+/glucose cotransporter of renal proximal tubular cells following oxidant injury.
源摘要(QG 实际输入)
It was reported that reactive oxygen metabolites play an important role in the pathogenesis of several renal diseases including glomerulonephritis, ischemia and acute tubular necrosis. However, the effect of oxidants and protective effect of sex steroid hormones on Na+/glucose cotransporter of renal proximal tubular cells is not yet elucidated. In the present study, we examined the effect of sex steroid hormones against tert-butyl hydroperoxide (t-BHP)-induced alteration of Na+/glucose cotransporter activity in primary cultured rabbit renal proximal tubule cells (PTCs). t-BHP inhibited alpha-methyl-D-glucopyranoside (alpha-MG) uptake in a dose-dependent manner. t-BHP-induced inhibition of alpha-MG uptake was due not to Km but to the decrease of Vmax. 0.5 mM t-BHP-induced inhibition of alpha-MG uptake was significantly blocked by estradiol-17beta, but not by progesterone and testosterone. This protective effect was not blocked by estrogen receptor antagonist or transcription and translation inhibitor. In addition, 0.5 mM t-BHP increased [3H]-arachidonic acid (AA) release and Ca2+ uptake. These effects of t-BHP were also significantly blocked by estradiol-17beta, but not by progesterone and testosterone. Protective efficacy of estradiol-17beta on t-BHP-induced inhibition of alpha-MG uptake is exhibited between antioxidants and iron chelators. In conclusion, estradiol-17beta, but not progesterone and testosterone, partially prevented t-BHP-induced inhibition of alpha-MG uptake through its antioxidant activity dependent upon phenol structures and inhibition of AA release and Ca2+ influx.
Q_low:Does estradiol-17beta protect renal proximal tubular cells from oxidant-induced inhibition of Na+/glucose cotransporter activity?
Q_high:Why does estradiol-17beta prevent oxidant-induced inhibition of Na+/glucose cotransporter activity in renal proximal tubular cells while progesterone and testosterone do not?
生成的答案(基于检索上下文,非源文档)
Yes, according to the provided context, estradiol-17beta protects renal proximal tubular cells from oxidant-induced inhibition of Na+/glucose cotransporter activity. Specifically, Context [1] reports that tert-butyl hydroperoxide (t-BHP), an oxidant, inhibits alpha-methyl-D-glucopyranoside (alpha-MG) uptake (a measure of Na+/glucose cotransporter activity) in primary cultured rabbit renal proximal tubule cells. This inhibition was significantly blocked by estradiol-17beta, but not by progesterone or testosterone. The study concludes that estradiol-17beta partially prevents this oxidant-induced inhibition through its antioxidant activity and by inhibiting arachidonic acid release and Ca2+ influx.
1. 科学性:两个问题是否是有意义的生物医学问题?
2. 依据性:问题相对“源摘要”是否站得住(全文存疑可点 PMID 核)?
3. Preference(该条进入了 DPO 偏好对)
胜出问题:Does estradiol-17beta protect renal proximal tubular cells from oxidant-induced inhibition of Na+/glucose cotransporter activity?
相对另一候选问题,胜出问题+其答案 确实更值得作为"更优"样本 吗?
备注
⚠️ 评完本条后再展开:系统自动判定(对比用,勿先看)
rubric=a / reason=hard_gate / verification=grounded

#9   PMID 35872467 (点 PMID 看全文核实)

Immature ALS-associated mutant superoxide dismutases form variable aggregate structures through distinct oligomerization processes.
源摘要(QG 实际输入)
Protein misfolding and aggregation are hallmarks of many diseases, including amyotrophic lateral sclerosis (ALS). In familial ALS, aberrant self-association of mutant Cu,Zn-superoxide dismutase (SOD1) is implicated as a key contributor to disease. Mutations have the largest impacts on the stability of the most immature form of SOD1, the unmetallated, disulfide-reduced monomer (apoSH SOD1). Here we demonstrate that, despite the marginal stability of apoSH SOD1, aggregation is little correlated with the degree of protein unfolding, and multiple modes of aggregation occur, depending on the mutation and solution conditions. Light scattering and atomic force microscopy reveal two distinct mutant SOD1 behaviours: high aggregator mutants form abundant small assemblies, while low aggregator mutants form fewer, more fibre-like aggregates. Attenuated total reflectance-Fourier transform infrared spectroscopy and Thioflavin T binding show the aggregates maintain native-like anti-parallel beta structure. These results provide new evidence that ALS-associated mutations promote the aggregation of apoSH SOD1 through multiple pathways, with broad implications for understanding mechanisms of protein self-association in disease and biotechnology.
Q_low:Do ALS-associated mutations in Cu,Zn-superoxide dismutase promote the aggregation of the unmetallated, disulfide-reduced monomer?
Q_high:How do ALS-associated mutations in Cu,Zn-superoxide dismutase influence the structural morphology of aggregates formed by the unmetallated, disulfide-reduced monomer?
生成的答案(基于检索上下文,非源文档)
Yes, based on the provided contexts, ALS-associated mutations in Cu,Zn-superoxide dismutase (SOD1) promote the aggregation of the unmetallated, disulfide-reduced monomer. Context [1] explicitly states that disulfide-reduced ALS variants (specifically A4V, L38V, G93A, and L106V) exhibit "increased populations of unfolded species" compared to the wild-type protein, which remains >95% folded. The text concludes that this "increased population of the unfolded state may favor aggregation over productive folding." Furthermore, Context [3] supports this by noting that metal-free (unmetallated) ALS variants (A4V, L38V, L106V, and G93A) show an "80- to 480-fold increase in the population of the unfolded monomeric states," which would "dramatically increase their propensity for aggregation." While Context [3] focuses on metal-free variants generally, Context [1] specifically links the disulfide-reduced state to these increased unfolded populations and subsequent aggregation risks.
1. 科学性:两个问题是否是有意义的生物医学问题?
2. 依据性:问题相对“源摘要”是否站得住(全文存疑可点 PMID 核)?
备注
⚠️ 评完本条后再展开:系统自动判定(对比用,勿先看)
rubric=tie / reason=tie / verification=grounded

#10   PMID 20549547 (点 PMID 看全文核实)

Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia.
源摘要(QG 实际输入)
Keeping in view the fact that genes coding microRNAs (miRNAs) have been found to be localized in chromosomal regions susceptible to genetic translocations, this study was addressed to identify and characterize the miRNAs that are present near/within the regions involved in genetic translocations characteristic of B-cell acute lymphoblastic leukemia (B-cell ALL). Out of six such identified miRNAs miR-196b was not only found to be significantly down-regulated in both EB-3 cell line as well as B-cell ALL patients as compared to that found in the corresponding controls, but also had the inherent capacity to down-regulate the highly expressed c-myc gene, a consequence of genetic translocation characteristic of EB-3 cells at both transcriptional and translational level. This phenomenon was in conformity with the observed reciprocal relationship between the expressed genes coding for miR-196b and c-myc in B-cells derived from ALL patients as well as c-myc gene was found to be a putative target of miR-196b as predicted by bioinformatic algorithms. Also down-regulation of c-myc gene was accompanied by decreased expressions of c-myc effector genes coding for hTERT, Bcl-2, and AATF. Based upon these results, we propose for the first time that miR-196b has the inherent capacity to down-regulate the overamplified c-myc gene recognized as a common pathognomonic feature leading to cancer in general and B-cell ALL in particular. Hence miR-196b can be assigned with the tumor suppressor function and can be of therapeutic importance in paving the way toward the treatment of B-cell ALL.
Q_low:Does miR-196b down-regulate the c-myc gene?
Q_high:How does the down-regulation of miR-196b affect the expression levels of c-myc effector genes such as hTERT, Bcl-2, and AATF in B-cell acute lymphoblastic leukemia?
生成的答案(基于检索上下文,非源文档)
Yes, miR-196b down-regulates the c-myc gene, but this effect is context-dependent. In B-cell acute lymphoblastic leukemia (B-cell ALL), miR-196b has been proven to down-regulate c-myc at both transcriptional and translational levels, acting as a tumor suppressor. However, in T-cell acute lymphoblastic leukemia (T-cell ALL), miR-196b loses this ability due to mutations in the 3'-untranslated region (3'-UTR) of the c-myc gene.
1. 科学性:两个问题是否是有意义的生物医学问题?
2. 依据性:问题相对“源摘要”是否站得住(全文存疑可点 PMID 核)?
3. Preference(该条进入了 DPO 偏好对)
胜出问题:Does miR-196b down-regulate the c-myc gene?
相对另一候选问题,胜出问题+其答案 确实更值得作为"更优"样本 吗?
备注
⚠️ 评完本条后再展开:系统自动判定(对比用,勿先看)
rubric=a / reason=hard_gate / verification=grounded
已评 0 / 10